26.04.2012 • NewsAir LiquideBenoît PotierIndustrial gases

Air Liquide Q1: Progressive Improvement in Activity

Air Liquide reported group revenue of €3,779 million for the first quarter 2012, up 6.7%. After a fourth quarter 2011 characterized by a slow-down in growth related to the global economic situation, first quarter 2012 reflects progressive growth in the volumes consumed by clients of the Group.

Gas & Services sales reached €3,443 million , up 4.0% on a comparable basis. Growth is steady in Developing Economies (11%), particularly in China, South America, Eastern Europe and the Middle East, and moderate in the Advanced Economies (2%). The lower level of equipment sales in Electronics, weighing on growth in the Asia zone, is compensated by the strength of the activity in North America.

Large Industries is benefitting from an increase in oxygen and hydrogen volumes, relative to the previous quarter. Industrial Merchant activity is improving, particularly helped by pricing. Healthcare remains solid, driven by hygiene growth. Excluding Equipment and Installation sales, Electronics is stable.

The new efficiency gains amount to €59 million and are in line with the objectives of the ALMA 2015 program. Net debt remains stable.

Benoît Potier, Chairman and CEO of the Air Liquide Group, stated:

"This first quarter is characterized by a progressive improvement in activity, particularly in the month of March, leading to quarterly revenue growth of nearly 7%.

"The increase of the order intake in Engineering & Construction and the stability at a high level of the Group's 12-month portfolio of opportunities are tangible signs of the continuing strength in our clients' investment projects; they reinforce our confidence in the medium term.

"All of the initiatives taken within the ALMA 2015 program continue to contribute to the improvement of our performance indicators, and allow us to achieve growth while controlling expenses.

"In this context, and barring a major economic downturn, Air Liquide continues to aim for growth in net profit in 2012."

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.